Home › NDC Lookup › Ingredients › Famotidine › 59651-0112-53
⚪image loading
(from DailyMed)

Famotidine 10 mg Tablet, Film Coated, 12,000-count — NDC 59651-112-53 (Billing 59651-0112-53)

by Aurobindo Pharma Limited · 12000 TABLET, FILM COATED in 1 BAG

This is a package of 12,000 tablets of Famotidine 10 mg Tablet, Film Coated from Aurobindo Pharma Limited, marketed since Apr 2016 and currently FDA-listed.

NDC 59651-0112-53
🏷️ FDA NDC (as labeled) 59651-112-53 billing pads the product segment with a zero
This package
Contains12,000-count Pack sizes2 compare ↓
Product page 59651-0112-12 Also comes in: 120000 tablets 59651-112-12
On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 59651-112-53 alone.

Record
FDA NDC Directory package listing · Drug for further processing
Code segments
59651 labeler · 112 product · 53 package
Package marketed since
Apr 26, 2016
Listing certified through
Dec 31, 2026
Barcode (UPC-A, from the NDC)
3 5965111253 3
FDA record last changed
Jul 24, 2026
⚠️
Other active recalls for Famotidine (different manufacturers) — 2 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Aug 6, 2026 — CGMP Deviations (Baxter Healthcare Corporation) · FDA recall D-0809-2026
Class I · Nov 6, 2025 — Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing. (Fresenius Kabi USA, LLC) · FDA recall D-0182-2026
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 59651-112-53
Product NDC 59651-112
11-digit billing NDC 59651011253
SPL Set ID 4f98e712-6cc7-44da-bdc6-8b3596fbbc61
DEA schedule Non-controlled
Marketing category DRUG FOR FURTHER PROCESSING
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2016-04-26
Dosage form TABLET, FILM COATED
Substance FAMOTIDINE
Why two NDCs? The FDA registers this code as 59651-112-53 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 59651-0112-53. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

📗 Our plain-language guide HelloPharmacist
  • It reduces stomach acid. Over-the-counter versions relieve and prevent heartburn from acid indigestion and sour stomach. Prescription versions treat ulcers, GERD and erosive esopha...
  • With the over-the-counter tablets, swallow one with water and do not chew it. To prevent heartburn, take it shortly before a food or drink that triggers it. Do not take more than 2...
  • Headache, dizziness, constipation and diarrhea are the most common, and they are usually mild. Call your doctor if you have confusion, hallucinations, seizures, a rash with swellin...
  • Not always. Famotidine can lower absorption of some drugs that need stomach acid and can raise tizanidine levels. Tell me or your doctor everything you take before you start.
📖 Read our full Famotidine guide →
6
Nutrient depletion considerations

Famotidine may be associated with lower levels of 6 nutrients — worth a chat with your pharmacist, not a cause for alarm.

🧪 Full Famotidine nutrient depletion report →
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 120000 tablets
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
59651-0112-12 59651-112-12 Main listing 120000 TABLET, FILM COATED in 1 BAG — — Active
59651-0112-53 You're viewing this 12000 TABLET, FILM COATED in 1 BAG — — Active

You're viewing the smallest of 2 pack sizes for this product.

Pack size FAQ

What quantity is in this package?
This is a 12,000-count package — 12000 tablet, film coated in 1 bag.
How does this package differ from NDC 59651-0112-12?
Both are Famotidine 10 mg Tablet, Film Coated — the drug itself is identical. This page's package is the 12,000-count one, while NDC 59651-0112-12 is the 120000 tablets package.
What NDC number is used to bill for this package of Famotidine 10 mg Tablet, Film Coated?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Famotidine 10 mg 70000-0048-01 LEADER/ 30 tablets $0.092 — FDA listed —
famotidine 10 mg 69230-0326-01 Camber 100 tablets $0.095 — Availability likely —
Famotidine 10 mg 68001-0494-04 BluePoint 30 tablets $0.095 — Availability likely —
foster and thrive acid reducer 10 mg 70677-1102-01 Strategic 1 tablet $0.095 — Availability likely —
good sense acid reducer 10 mg 00113-0141-65 L. 1 tablet $0.095 — Availability likely —
heartburn relief original strength 10 mg 00904-5529-52 Major 60 tablets $0.095 — Availability likely —
Famotidine 10 mg 46122-0735-65 Amerisource 30 tablets $0.095 — Availability likely —
famotidine 10 mg 83324-0003-30 CHAIN 30 tablets $0.096 — Availability likely —
Famotidine 10 mg 43602-0511-03 Ascent 300 tablets — — FDA listed —
heartburn relief original strength 10 mg 63187-0999-10 Proficient 10 tablets — — FDA listed —
Famotidine 10 mg 71205-0637-30 Proficient 30 tablets — — FDA listed —
acid relief 10 mg 11822-6141-00 Rite 1 tablet — — Discontinued —
Famotidine 10 mg 63941-0009-09 Best 30 tablets — — FDA listed —
Acid Controller Original Strength 10 mg 00363-0141-65 Walgreen 1 tablet — — Discontinued —
Heartburn Relief 10 mg 83059-0005-05 Shield 50 tablets — — FDA listed —
Heartburn Relief 10 mg 83059-0031-05 Shield 50 tablets — — FDA listed —
signature care acid controller 10 mg 21130-0249-65 Safeway 1 tablet — — Discontinued —
Famotidine 10 mg 55319-0408-01 FAMILY 60 tablets — — FDA listed —
acid reducer 10 mg 56062-0141-65 Publix 1 tablet — — FDA listed —
Famotidine 10 mg 63868-0583-30 Chain 30 tablets — — FDA listed —
Famotidine 10 mg 37835-0161-50 Bi-Mart 50 tablets — — FDA listed —
Famotidine 10 mg 53943-0100-30 Discount 30 tablets — — FDA listed —
Famotidine 10 mg 69842-0928-84 CVS 30 tablets — — FDA listed —
Famotidine 10 mgthis 59651-0112-53 Aurobindo 12000 tablets — — FDA listed —
Famotidine 10 mg 21130-0022-30 Albertsons 30 tablets — — FDA listed —
equaline heartburn prevention 10 mg 41163-0313-65 United 1 tablet — — FDA listed —
Acid Reducer Original Strength 10 mg 43598-0824-18 Dr.Reddys 180 tablets — — FDA listed —
Equate Famotidine 10 mg 49035-0507-75 Wal-Mart 90 tablets — — FDA listed —
Famotidine 10 mg 55681-0343-03 TWIN 300 tablets — — FDA listed —
acid controller 10 mg 37808-0301-65 H 1 tablet — — FDA listed —
acid reducer original strength 10 mg 42507-0141-75 HyVee 90 tablets — — FDA listed —
Famotidine 10 mg 58602-0705-09 Aurohealth 10 tablets — — FDA listed —
acid controller original strength 10 mg 59779-0141-39 CVS 30 tablets — — FDA listed —
Famotidine 10 mg 71821-0012-08 VKT 288461 tablets — — FDA listed —
Famotidine 10 mg 21130-0039-09 Better 30 tablets — — FDA listed —
heartburn relief 10 mg 41250-0493-65 Meijer 1 tablet — — FDA listed —
Famotidine 10 mg 54257-0180-07 Magno-Humphries, 90 tablets — — FDA listed —
Famotidine 10 mg 83324-0139-30 Chain 30 tablets — — FDA listed —
Famotidine 10 mg 66406-0100-00 Patheon 194174 tablets — — FDA listed —
famotidine 10 mg 66406-0461-00 Patheon 210000 tablets — — FDA listed —
Famotidine 10 mg 00363-4400-19 WALGREEN 90 tablets — — FDA listed —
Famotidine 10 mg 72657-0112-20 GLENMARK 200 tablets — — FDA listed —
Pepcid AC Original Strength 10 mg 16837-0872-10 Kenvue 10 tablets — — Discontinued —
TopCare Acid Reducer 10 mg 36800-0141-65 Topco 1 tablet — — FDA listed —
Famotidine 10 mg 55111-0118-04 Dr. 120 tablets — — FDA listed —
Famotidine 10 mg 69256-0002-47 HARRIS 30 tablets — — FDA listed —
Acid Controller 10 mg 21130-0771-75 Safeway 90 tablets — — FDA listed —
Famotidine 10 mg 57896-0317-03 GERI-CARE 30 tablets — — FDA listed —
Famotidine 10 mg 00363-9607-09 WALGREEN 30 tablets — — FDA listed —
Famotidine 10 mg 69842-0063-19 CVS 90 tablets — — FDA listed —
Original strength heartburn prevention 10 mg 41226-0719-06 KROGER 30 tablets — — FDA listed —
CareOne Acid Relief 10 mg 41520-0901-65 American 1 tablet — — Discontinued —
Famotidine 10 mg 49035-0589-19 Wal-Mart 90 tablets — — FDA listed —
Famotidine 10 mg 55319-0426-60 Family 60 tablets — — FDA listed —
dg health heartburn prevention original strength 10 mg 55910-0141-60 Dolgencorp, 1 tablet — — FDA listed —
Famotidine 10 mg 58602-0828-19 Aurohealth 90 tablets — — FDA listed —
Famotidine 10 mg 68016-0800-30 Chain 30 tablets — — FDA listed —
basic care acid reducer 10 mg 72288-0141-65 Amazon.com 1 tablet — — FDA listed —
Acid Reducer 10 mg 51316-0816-39 CVS 30 tablets — — FDA listed —
Acid Reducer 10 mg 72288-0756-75 Amazon.com 90 tablets — — FDA listed —
Heartburn Relief 10 mg 83059-0185-01 Shield 15 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2016
On the market since
Apr 2016
📍
2026
Currently FDA-listed
10 years listed
🔓
·
Generic versions listed
see equivalents
✅Generic appears available

FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available — see Therapeutic equivalents.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

We could not link this NDC to a current FDA Structured Product Label. An inactive-ingredient list is therefore not available from this source.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerAurobindo Pharma Limited
Labeler code59651
First marketedApr 2016
Product typeDrug For Further Processing
Portfolio1,456 products on file

More NDCs from Aurobindo Pharma Limited labeler code 59651

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full FDA label FDA SPL

The complete FDA label for this product, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 FDA label
📄 FDA label 19 words ▾

No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Famotidine (matched by generic name) — the program that covers self-administered drugs. 29 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Famotidine. CMS lists 2 products for this generic; we show the highest-spend one. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$40.22M
Claims incl. refills
3.8M
Beneficiaries
2.6M
Spend / beneficiary
$15.35
Spend / claim
$10.62
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

About this NDC listing & data coverage

Listed for further processing / repackaging

What "drug for further processing" means

FDA lists this package under the "drug for further processing" marketing category: Aurobindo Pharma Limited supplies it to other companies for further processing or repackaging (blister cards that are later repackaged or co-packaged are a common example). The units themselves are a finished dosage form — which is why pricing or Medicaid data can still appear — but this exact package code may not be the presentation a retail pharmacy dispenses.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Drug For Further Processing". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Aurobindo Pharma Limited. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 120000 tablets (59651-0112-12). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Aurobindo Pharma Limited is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 59651-0111-37 · Aurobindo 59651-0113-05 · Aurobindo →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.